Roche perspectives on Tamiflu

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comments on Roche

As the original announcement for this Workshop observed, 1996 marks the fortieth anniversary of Chomsky's demonstration of the non-regularity of natural language | more specifically natural language syntax. 1 At rst glance the computational import of this result may seem obvious: clearly one could not construct a nite-state automaton capable of handling all sentences of a natural language. Yet ...

متن کامل

Tamiflu: "a nice little earner".

Viewed with hindsight, the story of flu antiviral drugs seems to be a classic story of “big pharma” greed. On the back of media hype and unfulfilled fears, a new medicine backed by only modest clinical data became a “blockbuster” generating billions of dollars for its producer. The reality is more nuanced, and the tale could easily instead have been a commercial and public health nightmare. The...

متن کامل

The generalized Roche model

Some exact analytical formulas are presented for the generalized Roche model of rotating star. The gravitational field of the central core is described by the model of two equal-mass point centers placed symmetrically at rotation axis with the pure imaginary z coordinates. The all basic parameters of the critical figure of the rotating massless envelope are presented in analytical form. The exi...

متن کامل

Roche Investor Relations ASCO

 Abstract 9025 Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with advanced non-small cell lung cancer (NSCLC). Poster Board #351  Abstract 9064 Updated efficacy and safety of the j-alex study comparing alectinib (ALC) with crizotinib (CRZ) in ALK-inhibitor naïve ALK fusion positive non-small cell lung cancer (ALK+ NSCLC). Poster Board #390  Abstract 9092 Atezolizumab...

متن کامل

Tamiflu: 14 flu seasons and still questions.

In the midst of a worse than average influenza season, clinicians are increasingly prescribing antiviral agents, especially oseltamivir (Tamiflu). Oseltamivir, an oral neuraminidase inhibitor, was first approved for use by the US Food and Drug Administration in 1999. It is indicated “for the treatment of acute, uncomplicated illness due to influenza infection in patients 2 weeks of age and olde...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Clinical Microbiology and Infection

سال: 2015

ISSN: 1198-743X

DOI: 10.1016/j.cmi.2015.01.014